Cargando…
The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1991
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977484/ https://www.ncbi.nlm.nih.gov/pubmed/1834157 |
| _version_ | 1782135271200915456 |
|---|---|
| author | Thompson, P. Wilson, P. Osborne, R. Slevin, M. Wiltshaw, F. Blake, P. Harper, P. Coleman, R. Williams, C. Sweetenham, J. |
| author_facet | Thompson, P. Wilson, P. Osborne, R. Slevin, M. Wiltshaw, F. Blake, P. Harper, P. Coleman, R. Williams, C. Sweetenham, J. |
| author_sort | Thompson, P. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1977484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1991 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19774842009-09-10 The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. Thompson, P. Wilson, P. Osborne, R. Slevin, M. Wiltshaw, F. Blake, P. Harper, P. Coleman, R. Williams, C. Sweetenham, J. Br J Cancer Research Article Nature Publishing Group 1991-11 /pmc/articles/PMC1977484/ /pubmed/1834157 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Thompson, P. Wilson, P. Osborne, R. Slevin, M. Wiltshaw, F. Blake, P. Harper, P. Coleman, R. Williams, C. Sweetenham, J. The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title | The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title_full | The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title_fullStr | The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title_full_unstemmed | The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title_short | The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study. |
| title_sort | clinical activity of cyproterone acetate in advanced ovarian carcinoma. a london gynaecology oncology group study. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977484/ https://www.ncbi.nlm.nih.gov/pubmed/1834157 |
| work_keys_str_mv | AT thompsonp theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT wilsonp theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT osborner theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT slevinm theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT wiltshawf theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT blakep theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT harperp theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT colemanr theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT williamsc theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT sweetenhamj theclinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT thompsonp clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT wilsonp clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT osborner clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT slevinm clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT wiltshawf clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT blakep clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT harperp clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT colemanr clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT williamsc clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy AT sweetenhamj clinicalactivityofcyproteroneacetateinadvancedovariancarcinomaalondongynaecologyoncologygroupstudy |